MedTrace Logo

Impact of Collaborative Care for Pregnant Women With Opioid Use Disorder in Low-Resource Obstetric Settings

NCT06956352 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1350

Last updated 2025-10-14

No results posted yet for this study

Summary

The investigators seek to adapt a collaborative care model (CCM) for community-based, low-resource obstetric settings and to test the effects of this adapted CCM on health outcomes among Pregnant, postpartum, and parenting person (PPPP) with Opioid use disorder (OUD) and their families. To achieve this goal, investigators will conduct a nonrandomized, Type 1 hybrid implementation-effectiveness study across 3 community-based, low-resource obstetric sites in Northwest PA, a region with rates of maternal opioid-related diagnoses 4 times higher than national averages.

Conditions

Interventions

BEHAVIORAL

Usual Care

Usual, referral-based, care.

BEHAVIORAL

Adapted Collaborative Care Model (CCM)

Person-centered, recovery supports.

Sponsors & Collaborators

  • Magee-Women's Research Institute

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Elizabeth Krans, MD · University of Pittsburgh

  • Marian Jarlenski, PhD · University of Pittsburgh

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-24
Primary Completion
2030-08-31
Completion
2031-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06956352 on ClinicalTrials.gov